Radiofrequency ablation for hepatocellular carcinoma: 10-Year outcome and prognostic factors

American Journal of Gastroenterology

Volumn 107, Issue 4, 2012, Pages 569-577

  Shiina, Shuichiro ^a   Tateishi, Ryosuke ^a   Arano, Toru ^a   Uchino, Koji ^a   Enooku, Kenichiro ^a   Nakagawa, Hayato ^a   Asaoka, Yoshinari ^a   Sato, Takahisa ^a   Masuzaki, Ryota ^a   Kondo, Yuji ^a   Goto, Tadashi ^a   Yoshida, Haruhiko ^a   Omata, Masao ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; LECTIN;

AGED; ARTICLE; BONE METASTASIS; BRAIN INFARCTION; BURN; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; DIGESTIVE SYSTEM PERFORATION; FEMALE; FOLLOW UP; GALLBLADDER DISEASE; HEMATOTHORAX; HEMOBILIA; HEMOPERITONEUM; HEPATITIS C VIRUS; HUMAN; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER FAILURE; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEURA EFFUSION; PNEUMOTHORAX; PRIORITY JOURNAL; PROTHROMBIN TIME; RADIOFREQUENCY ABLATION; SURVIVAL RATE; THERAPY EFFECT; THROMBOCYTE COUNT; TREATMENT DURATION; TUMOR ABLATION; TUMOR GROWTH; TUMOR SEEDING;

AGED; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LECTINS; LIVER NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; PROTHROMBIN; REOPERATION; RISK FACTORS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84859586321     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.425     Document Type: Article

References (53)

1. Parkin DM, Bray F, Ferlay J et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6. (Pubitemid 32911406)
2. Borie F, Bouvier AM, Herrero A et al. Treatment and prognosis of hepatocellular carcinoma: a population based study in France. J Surg Oncol 2008;98:505-9.
3. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003;52 (Suppl 3):iii1-8. (Pubitemid 36520856)
4. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-17. (Pubitemid 37518510)
5. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36. (Pubitemid 43112690)
6. Shiina S, Teratani T, Obi S et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122-30. (Pubitemid 41002049)
7. Lin SM, Lin CJ, Lin CC et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm. Gastroenterology 2004;127:1714-23.
8. Lin SM, Lin CJ, Lin CC et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54:1151-6.
9. Lencioni RA, Allgaier HP, Cioni D et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235-40. (Pubitemid 36736097)
10. Shiina S, Teratani T, Obi S et al. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002;62 (Suppl 1):64-8. (Pubitemid 34702022)
11. N'Kontchou G, Mahamoudi A, Aout M et al. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009;50:1475-83.
12. Tateishi R, Shiina S, Teratani T et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005;103:1201-9. (Pubitemid 40328091)
13. Lencioni R, Cioni D, Crocetti L et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005;234:961-7. (Pubitemid 40250844)
14. Choi D, Lim HK, Rhim H et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007;17:684-92.
15. Livraghi T, Meloni F, Di Stasi M et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 2008;47:82-9. (Pubitemid 351171044)
16. Buscarini L, Buscarini E, Di Stasi M et al. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001;11:914-21. (Pubitemid 32755549)
17. Raut CP, Izzo F, Marra P et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 2005;12:616-28. (Pubitemid 41126091)
18. Teratani T, Yoshida H, Shiina S et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 2006;43:1101-8. (Pubitemid 43724634)
19. Araki T, Itai Y, Furui S et al. Dynamic CT densitometry of hepatic tumors. AJR Am J Roentgenol 1980;135:1037-43. (Pubitemid 11236978)
20. Kondo Y, Yoshida H, Tateishi R et al. Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion technique. Br J Surg 2008;95:996-1004.
21. Kondo Y, Yoshida H, Shiina S et al. Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract. Br J Surg 2006;93:1277-82. (Pubitemid 44547029)
22. Goldberg SN, Grassi CJ, Cardella JF et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005;235:728-39. (Pubitemid 40695866)
23. Gaynor JJ, Feuer EJ, Tan CC et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc 1993;88:400-9.
24. Sacks D, McClenny TE, Cardella JF et al. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol 2003;14:S199-202.
25. Sala M, Llovet JM, Vilana R et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004;40:1352-60. (Pubitemid 39657009)
26. Lencioni R, Bartolozzi C, Caramella D et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer 1995;76:1737-46.
27. Castellano L, Calandra M, Del Vecchio Blanco C e t al. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients. J Hepatol 1997;27:862-70. (Pubitemid 27454830)
28. Franco D, Capussotti L, Smadja C et al. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology 1990;98:733-8.
29. Takayasu K, Arii S, Ikai I et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006;131:461-9. (Pubitemid 44142456)
30. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-40.
31. Minagawa M, Makuuchi M, Takayama T et al. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003;238:703-10. (Pubitemid 38182262)
32. Poon RT, Fan ST, Lo CM et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002;235:373-82. (Pubitemid 34183888)
33. Ishii H, Okada S, Nose H et al. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1996;77:1792-6. (Pubitemid 26125178)
34. Mulier S, Ni Y, Jamart J et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005;242:158-71. (Pubitemid 41033431)
35. Koike Y, Shiratori Y, Sato S et al. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 2001;91:561-9. (Pubitemid 32105702)
36. Capussotti L, Muratore A, Amisano M et al. Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival - a European single center experience. Eur J Surg Oncol 2005;31:986-93. (Pubitemid 41671112)
37. Taketomi A, Kitagawa D, Itoh S et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. J Am Coll Surg 2007;204:580-7. (Pubitemid 46428578)
38. Imamura H, Seyama Y, Kokudo N et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003;138:1198-206; discussion 206.
39. Park YK, Kim BW, Wang HJ et al. Hepatic resection for hepatocellular carcinoma meeting Milan criteria in Child-Turcotte-Pugh class a patients with cirrhosis. Transplant Proc 2009;41:1691-7.
40. Wang CC, Iyer SG, Low JK et al. Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2009;16:1832-42.
41. Kamiyama T, Nakanishi K, Yokoo H et al. Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization. Ann Surg Oncol 2009;16:1560-71.
42. Yamamoto J, Kosuge T, Saiura A et al. Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria. Jpn J Clin Oncol 2007;37:287-95. (Pubitemid 47090681)
43. Nuzzo G, Giuliante F, Gauzolino R et al. Liver resections for hepatocellular carcinoma in chronic liver disease: experience in an Italian centre. Eur J Surg Oncol 2007;33:1014-8. (Pubitemid 47408730)
44. Hanazaki K, Kajikawa S, Shimozawa N et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 2000;191:381-8.
45. Shimada K, Sano T, Sakamoto Y et al. A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. Cancer 2005;104:1939-47. (Pubitemid 41513178)
46. Chen MS, Li JQ, Zheng Y et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243:321-8. (Pubitemid 43327762)
47. Lu MD, Kuang M, Liang LJ et al. [Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial]. Zhonghua Yi Xue Za Zhi 2006;86:801-5.
48. Hong SN, Lee SY, Choi MS et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005;39:247-52.
49. Yamagiwa K, Shiraki K, Yamakado K et al. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. J Gastroenterol Hepatol 2008;23:482-90. (Pubitemid 351342072)
50. Yamakado K, Nakatsuka A, Takaki H et al. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 2008;247:260-6.
51. Vivarelli M, Guglielmi A, Ruzzenente A et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004;240:102-7. (Pubitemid 38808241)
52. Guglielmi A, Ruzzenente A, Valdegamberi A et al. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2008;12:192-8.
53. Abu-Hilal M, Primrose JN, Casaril A et al. Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 2008;12:1521-6.